Aishwarya Lifesciences is a leading Indian biotechnology and pharmaceutical manufacturing company, established in 2010 and headquartered in Mumbai. As a subsidiary of the Aishwarya Group, the company specializes in sterile formulations, particularly in the IVF and parenteral solutions markets. It is recognized as one of the top five manufacturers of sterile Form-Fill-Seal (FFS) formulations in India.

The company operates four specialized manufacturing units with over 30 production lines, producing around 900 products annually. Its facilities are WHO-GMP certified and comply with EU and US FDA standards, ensuring high-quality production. Aishwarya Lifesciences emphasizes innovation, launching more than 25 new molecules and 80 product innovations each year. The company also has a strong market presence across India and partnerships in 53 countries, exporting to regions including Southeast Asia, Africa, and Europe.